文献速递血管炎

疑似巨细胞动脉炎患者血管超声诊断准确性(EUREKA):一项前瞻性、多中心、非干预性队列研究

Diagnostic accuracy of vascular ultrasound in patients with suspected giant cell arteritis (EUREKA): a prospective, multicentre, non-interventional, cohort study.
PubMed 文献 · Lancet Rheumatol · 2021-10-26

EUREKA研究在3家丹麦医院连续纳入50岁以上疑似巨细胞动脉炎患者,行双侧颞动脉、面动脉、颈总动脉及腋动脉超声,7天内行颞动脉活检,以6个月随访确诊为参考标准。超声诊断敏感性94%、特异性84%,超声为6个月临床确诊的最强基线预测因子(粗OR 76.6)。作者认为由系统培训的操作者使用适当设备时,血管超声可能有效替代颞动脉活检作为一线诊断方法。

要点

  • 106例疑似巨细胞动脉炎患者中,6个月临床确诊62例(58%),颞动脉活检阳性46例(43%)。
  • 血管超声诊断巨细胞动脉炎的敏感性为94%(95%CI 84-98),特异性为84%(95%CI 70-93)。
  • 超声是6个月临床确诊的最强基线预测因子,粗OR 76.6(95%CI 21.0-280.0),校正性别和年龄后OR 141.0(95%CI 27.0-743.0)。

核心结论

  • 由系统培训的超声操作者使用适当设备时,血管超声可能有效替代颞动脉活检作为疑似巨细胞动脉炎患者的一线诊断方法。

研究设计与样本

  • 前瞻性、多中心、非干预性队列研究(EUREKA),连续纳入3家丹麦医院50岁以上临床疑似巨细胞动脉炎患者,最终106例纳入意向诊断人群。
  • 所有参与者行双侧颞动脉、面动脉、颈总动脉及腋动脉超声,并在开始糖皮质激素治疗7天内行颞动脉活检,随访6个月,以6个月随访确诊的临床诊断为参考标准。

主要发现

  • 106例患者平均年龄72.7岁(SD 7.9),女性63例(59%),男性43例(41%)。
  • 颞动脉活检阳性46例(43%),6个月临床确诊巨细胞动脉炎62例(58%);颞动脉活检敏感性74%(95%CI 62-84),特异性100%(95%CI 92-100)。
  • 颅动脉超声在所有颞动脉活检阳性患者中均为阳性;超声阳性而活检阴性的12例患者中,7例(58%)经其他影像方法证实为大血管型巨细胞动脉炎。
  • 超声诊断巨细胞动脉炎的敏感性94%(84-98),特异性84%(70-93)。
  • Logistic回归分析显示超声是6个月临床确诊巨细胞动脉炎的最强基线预测因子:粗OR 76.6(95%CI 21.0-280.0),校正性别和年龄后OR 141.0(95%CI 27.0-743.0)。

关键数值与推荐

  • 颅动脉超声血管炎定义:均匀、低回声的内膜-中膜复合体增厚且压缩征阳性。
  • 腋动脉超声血管炎定义:均匀内膜-中膜复合体厚度≥1 mm;颈总动脉定义:均匀内膜-中膜复合体厚度≥1.5 mm。

临床怎么用

  • 作者认为,由系统培训的超声操作者使用适当设备时,血管超声可能有效替代颞动脉活检作为疑似巨细胞动脉炎患者的一线诊断方法。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Temporal artery biopsy is considered the diagnostic gold standard for giant cell arteritis, despite approximately 39% of patients who are negative for the condition by biopsy subsequently being given a clinical diagnosis of giant cell arteritis. We aimed to assess the diagnostic accuracy of ultrasound examination in patients with suspected giant cell arteritis. METHODS: In this prospective, multicentre, non-interventional, cohort study (evaluation of ultrasound's role in patients suspected of having extracranial and cranial giant cell arteritis; EUREKA), we consecutively recruited patients aged 50 years or older, with clinically suspected giant cell arteritis from three Danish hospitals (South West Jutland Hospital in Esbjerg, Silkeborg Regional Hospital, and Rigshospitalet, Glostrup). Participants had a bilateral ultrasound of the temporal, facial, common carotid, and axillary arteries. Ultrasounds were done by ultrasonographers who were systematically trained in vascular ultrasound using appropriate equipment and settings. Participants then had a temporal artery biopsy within 7 days of initiation of corticosteroid treatment. A blinded ultrasound expert assessed all ultrasound images. Ultrasound vasculitis was defined in cranial arteries as a homogeneous, hypoechoic, intimamedia complex thickness and a positive compression sign and as a homogeneous intimamedia complex of 1 mm in thickness or wider in the axillary arteries and of 1·5 mm thickness or wider in the common carotid artery. Participants were followed up at 6 months. During this 6 month period, clinicians were able to collect data from all clinical examinations to enable a full clinical diagnosis at 6 months. Clinical diagnosis was based on the expert opinion of the treating rheumatologist. The diagnostic criterion standard was diagnosis confirmed after 6 months of follow-up. We used logistic regression analyses to calculate the odds ratio and 95% CI of ultrasound as a predictor for giant cell arteritis. FINDINGS: Between April 1, 2014, and July 31, 2017, 118 patients were screened for inclusion, of whom 106 had both ultrasound examinations and an eligible temporal artery biopsy and were included in the intention-to-diagnose population. The mean age was 72·7 years (SD 7·9), 63 (59%) participants were women, and 43 (41%) were men. Temporal artery biopsy was positive in 46 (43%) of 106 patients, and 62 (58%) of 106 patients had a clinically confirmed diagnosis of giant cell arteritis at 6 months (temporal artery biopsy sensitivity 74% [95% CI 62-84], specificity 100% [95% CI 92-100]). Cranial artery ultrasound was positive in all patients who had a positive temporal artery biopsy, and seven (58%) of 12 patients who were positive by ultrasound and negative by temporal artery biopsy were confirmed to have large-vessel giant cell arteritis via other imaging methods. The sensitivity of ultrasound diagnosis of giant cell arteritis was 94% (84-98) and specificity was 84% (70-93). Logistic regression analysis confirmed that ultrasound was the strongest baseline predictor for a clinically confirmed diagnosis of giant cell arteritis at 6 months (crude odds ratio 76·6 [95% CI 21·0-280·0]; adjusted for sex and age 141·0 [27·0-743·0]). INTERPRETATION: Vascular ultrasound might effectively replace temporal artery biopsy as a first-line diagnostic method in patients suspected of having giant cell arteritis when done by systematically trained ultrasonographers using appropriate equipment and settings. FUNDING: The Institute for Regional Research at Hospital of Southwest Jutland, Esbjerg, Denmark.

来源:Lancet Rheumatol,查看原文。版权归原作者所有。

引用

  1. Chrysidis S, Døhn UM, Terslev L, et al. Diagnostic accuracy of vascular ultrasound in patients with suspected giant cell arteritis (EUREKA): a prospective, multicentre, non-interventional, cohort study. Lancet Rheumatol. 2021. PMID: 38287632. doi:10.1016/S2665-9913(21)00246-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。